Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase Inhibitors
作者： David Williams , John Feely
DOI: 10.2165/00003088-200241050-00003
关键词: HMG-CoA reductase 、 Drug interaction 、 Pharmacology 、 Fluvastatin 、 Pravastatin 、 Cerivastatin 、 Statin 、 Lovastatin 、 Atorvastatin 、 Medicine
摘要: The HMG-CoA reductase inhibitors (statins) are effective in both the primary and secondary prevention of ischaemic heart disease. As a group, these drugs are well tolerated apart from …
springer.com
elsevier.com
sci-hub.se 参考文章(251)
Brescia D, DeVault Ar, Pan Hy, Willard Da, Ivashkiv E, McGovern Me, Whigan Db, Effect of food on pravastatin pharmacokinetics and pharmacodynamics. International journal of clinical pharmacology, therapy, and toxicology. ,vol. 31, pp. 291- 294 ,(1993)
Jochem Alsenz, Hans Steffen, Rainer Alex, Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers. Pharmaceutical Research. ,vol. 15, pp. 423- 428 ,(1998) , 10.1023/A:1011924314899
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels The New England Journal of Medicine. ,vol. 339, pp. 1349- 1357 ,(1998) , 10.1056/NEJM199811053391902
R Gilad, Y Lampl, Rhabdomyolysis induced by simvastatin and ketoconazole treatment. Clinical Neuropharmacology. ,vol. 22, pp. 295- 297 ,(1999)
B Koçak, S Korkmaz, O Ozdemir, Y Uzun, M Boran, V Gökçe, A case with severe rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy--a case report. Angiology. ,vol. 51, pp. 695- 697 ,(2000)
N. Given, T. Trenque, H. Choisy, M.-L. Germain, Pravastatin: interaction with oral anticoagulant? BMJ. ,vol. 312, pp. 886- 886 ,(1996) , 10.1136/BMJ.312.7035.886B
J A Tobert, P J Gruer, J M Vega, M Dobrinska, Calcium channel blocker-simvastatin interaction. Clinical Pharmacology & Therapeutics. ,vol. 65, pp. 583- 585 ,(1999)
M Viganò, M B Regazzi, I Iacona, C Campana, G Perani, A Gavazzi, V Raddato, C Lesi, Altered disposition of pravastatin following concomitant drug therapy with cyclosporin A in transplant recipients. International Samuel L. Kountz symposium on renal disease and transplantation in blacks. ,vol. 25, pp. 2732- 2734 ,(1993)
Wilmarth J, Kamjoo P, Kobashigawa Ja, Brownfield E, Kawata N, Chuck C, Murphy Fl, Moriguchi Jd, Stevenson Lw, Leonard L, Low-dose lovastatin safely lowers cholesterol after cardiac transplantation. Circulation. ,vol. 82, ,(1990)
C. W. K. Lam, A. Y. M. Wang, Y. T. Lee, S. F. Lui, P. K. T. Li, T. W. L. Mak, C. B. Leung, K. N. Lai, The interaction of fluvastatin and cyclosporin A in renal transplant patients. International Journal of Clinical Pharmacology and Therapeutics. ,vol. 33, pp. 246- 248 ,(1995)